Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 260

1.

From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis.

Armstrong AW, Siegel MP, Bagel J, Boh EE, Buell M, Cooper KD, Callis Duffin K, Eichenfield LF, Garg A, Gelfand JM, Gottlieb AB, Koo JY, Korman NJ, Krueger GG, Lebwohl MG, Leonardi CL, Mandelin AM, Menter MA, Merola JF, Pariser DM, Prussick RB, Ryan C, Shah KN, Weinberg JM, Williams MO, Wu JJ, Yamauchi PS, Van Voorhees AS.

J Am Acad Dermatol. 2016 Nov 22. pii: S0190-9622(16)30909-4. doi: 10.1016/j.jaad.2016.10.017. [Epub ahead of print]

PMID:
27908543
2.

Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.

Totri CR, Eichenfield LF, Logan K, Proudfoot L, Schmitt J, Lara-Corrales I, Sugarman J, Tom W, Siegfried E, Cordoro K, Paller AS, Flohr C.

J Am Acad Dermatol. 2016 Nov 14. pii: S0190-9622(16)30832-5. doi: 10.1016/j.jaad.2016.09.021. [Epub ahead of print]

PMID:
27855965
3.

Filling in Pediatric Acne Practice Gaps: A Prospective Multicenter Study of Case-Based Education.

Feldstein S, Afshar M, Krakowski AC, Eichenfield LF.

J Adolesc Health. 2016 Nov;59(5):549-554. doi: 10.1016/j.jadohealth.2016.07.013.

PMID:
27638004
4.

Epidemiologic Analysis of Onychomycosis in the San Diego Pediatric Population.

Totri CR, Feldstein S, Admani S, Friedlander SF, Eichenfield LF.

Pediatr Dermatol. 2016 Oct 4. doi: 10.1111/pde.12986. [Epub ahead of print]

PMID:
27699839
5.
6.

Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment.

Ovejero D, Lim YH, Boyce AM, Gafni RI, McCarthy E, Nguyen TA, Eichenfield LF, DeKlotz CM, Guthrie LC, Tosi LL, Thornton PS, Choate KA, Collins MT.

Osteoporos Int. 2016 Dec;27(12):3615-3626.

PMID:
27497815
8.

High-dose isotretinoin: Bigger dents in wallets?

Haddock ES, Eichenfield LF.

J Am Acad Dermatol. 2016 Aug;75(2):e75-6. doi: 10.1016/j.jaad.2016.02.1244. No abstract available.

PMID:
27444097
9.

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.

Paller AS, Tom WL, Lebwohl MG, Blumenthal RL, Boguniewicz M, Call RS, Eichenfield LF, Forsha DW, Rees WC, Simpson EL, Spellman MC, Stein Gold LF, Zaenglein AL, Hughes MH, Zane LT, Hebert AA.

J Am Acad Dermatol. 2016 Sep;75(3):494-503.e4. doi: 10.1016/j.jaad.2016.05.046.

11.

Altered proliferation and networks in neural cells derived from idiopathic autistic individuals.

Marchetto MC, Belinson H, Tian Y, Freitas BC, Fu C, Vadodaria KC, Beltrao-Braga PC, Trujillo CA, Mendes AP, Padmanabhan K, Nunez Y, Ou J, Ghosh H, Wright R, Brennand KJ, Pierce K, Eichenfield L, Pramparo T, Eyler LT, Barnes CC, Courchesne E, Geschwind DH, Gage FH, Wynshaw-Boris A, Muotri AR.

Mol Psychiatry. 2016 Jul 5. doi: 10.1038/mp.2016.95. [Epub ahead of print]

PMID:
27378147
12.

Study of the Atopic March: Development of Atopic Comorbidities.

Schneider L, Hanifin J, Boguniewicz M, Eichenfield LF, Spergel JM, Dakovic R, Paller AS.

Pediatr Dermatol. 2016 Jul;33(4):388-98. doi: 10.1111/pde.12867.

PMID:
27273433
13.

Hormonal Contraceptives and Acne: A Retrospective Analysis of 2147 Patients.

Lortscher D, Admani S, Satur N, Eichenfield LF.

J Drugs Dermatol. 2016 Jun 1;15(6):670-4.

PMID:
27272072
14.

OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study.

Hanifin JM, Ellis CN, Frieden IJ, Fölster-Holst R, Stein Gold LF, Secci A, Smith AJ, Zhao C, Kornyeyeva E, Eichenfield LF.

J Am Acad Dermatol. 2016 Aug;75(2):297-305. doi: 10.1016/j.jaad.2016.04.001.

15.

Debates in allergy medicine: Specific immunotherapy in children with atopic dermatitis, the "con" view.

Ginsberg DN, Eichenfield LF.

World Allergy Organ J. 2016 Apr 18;9:16. doi: 10.1186/s40413-016-0107-2.

16.

Consensus Conference on Clinical Management of pediatric Atopic Dermatitis.

Galli E, Neri I, Ricci G, Baldo E, Barone M, Belloni Fortina A, Bernardini R, Berti I, Caffarelli C, Calamelli E, Capra L, Carello R, Cipriani F, Comberiati P, Diociaiuti A, El Hachem M, Fontana E, Gruber M, Haddock E, Maiello N, Meglio P, Patrizi A, Peroni D, Scarponi D, Wielander I, Eichenfield LF.

Ital J Pediatr. 2016 Mar 2;42:26. doi: 10.1186/s13052-016-0229-8. Review.

17.

Comparing the effect of bleach and water baths on skin barrier function in atopic dermatitis: a split-body randomized controlled trial.

Shi VY, Foolad N, Ornelas JN, Hassoun LA, Monico G, Takeda N, Saric S, Prakash N, Eichenfield LF, Sivamani RK.

Br J Dermatol. 2016 Jul;175(1):212-4. doi: 10.1111/bjd.14483. No abstract available.

PMID:
26875771
18.

Walter (Wally) Burgdorf, M.D., 1943-2015.

Frieden I, Eichenfield L.

Pediatr Dermatol. 2016 Mar-Apr;33(2):243. doi: 10.1111/pde.12792. No abstract available.

PMID:
26856971
19.

"EB, or Not EB?" Neonatal Desquamative Impetigo in a Degloving Pattern.

Nguyen TA, Wang AS, Eichenfield LF, Barrio V.

Pediatr Dermatol. 2016 Mar-Apr;33(2):e147-8. doi: 10.1111/pde.12766.

PMID:
26821848
20.

Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Reveals a More Atherogenic Profile.

Tom WL, Playford MP, Admani S, Natarajan B, Joshi AA, Eichenfield LF, Mehta NN.

J Invest Dermatol. 2016 Jan;136(1):67-73. doi: 10.1038/JID.2015.385.

Items per page

Supplemental Content

Loading ...
Support Center